HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain.

Abstract
A series of fused tricyclic mGluR1 antagonists containing a pyridone ring were synthesized. In vitro, these antagonists were potent against both human and rat isozymes, as well as selective for inhibiting mGluR1 over mGluR5. When dosed orally, several examples were active in vivo in a rat SNL test.
AuthorsChad E Bennett, Duane A Burnett, William J Greenlee, Chad E Knutson, Peter Korakas, Cheng Li, Deen Tulshian, Wen-Lian Wu, Rosalia Bertorelli, Silva Fredduzzi, Mariagrazia Grilli, Gianluca Lozza, Angelo Reggiani, Alessio Veltri
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 22 Issue 4 Pg. 1575-8 (Feb 15 2012) ISSN: 1464-3405 [Electronic] England
PMID22266036 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Analgesics
  • Pyridones
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor type 1
Topics
  • Administration, Oral
  • Analgesics (pharmacology)
  • Animals
  • Cells, Cultured
  • Cyclization
  • Humans
  • Inhibitory Concentration 50
  • Molecular Structure
  • Neuralgia (drug therapy)
  • Protein Binding (drug effects)
  • Pyridones (chemical synthesis, chemistry, pharmacology)
  • Rats
  • Receptors, Metabotropic Glutamate (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: